Stock Earnings

Question 1

BridgeBio Pharma Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, BridgeBio Pharma Inc'in toplam varlıkları $919 olup, net loss $-535'dir.

Question 2

BBIO'ün temel finansal oranları nelerdir?

Accepted Answer

BridgeBio Pharma Inc'in cari oranı 0.38, net kâr marjı -242.08, hisse başına satış $1.18'dir.

Question 3

BridgeBio Pharma Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

BridgeBio Pharma Inc largest revenue segment is Transformative Medicines, at a revenue of 221,902,000 in the most earnings release.For geography, EMEA is the primary market for BridgeBio Pharma Inc, at a revenue of 132,031,690.

Question 4

BridgeBio Pharma Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre BridgeBio Pharma Inc'in net loss $-535'dir.

Question 5

BridgeBio Pharma Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, BridgeBio Pharma Inc'in yükümlülüğü 2,387'dir.

Question 6

BridgeBio Pharma Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

BridgeBio Pharma Inc'in toplam tedavüldeki hisse sayısı 190.04'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	353	221	9	77	69	8
Revenue Growth (YoY)	63%	2,356%	-88%	12%	763%	-80%
Cost of Revenue	14	3	2	3	3	0
Gross Profit	338	218	6	74	66	8
Selling, General & Admin	467	288	150	143	192	145
Research & Development	465	506	455	399	451	337
Operating Expenses	933	795	606	542	643	482
Other Non Operating Income (Expenses)	32	4	0	-7	35	1
Pretax Income	-803	-542	-653	-484	-586	-505
Income Tax Expense	1	1	--	--	--	--
Net Income	-797	-535	-643	-481	-562	-448
Net Income Growth	82%	-17%	34%	-14%	25%	72%
Shares Outstanding (Diluted)	191.85	186.07	162.79	147.47	144.36	118
Shares Change (YoY)	2%	14%	10%	2%	22%	12%
EPS (Diluted)	-4.15	-2.87	-3.95	-3.26	-3.9	-3.8
EPS Growth	79%	-27%	21%	-16%	3%	53%
Free Cash Flow	-597	-529	-529	-425	-511	-407
Free Cash Flow Per Share	-3.11	-2.84	-3.24	-2.88	-3.53	-3.44
Gross Margin	95.75%	98.64%	66.66%	96.1%	95.65%	100%
Operating Margin	-168.27%	-261.08%	-6,655.55%	-607.79%	-834.78%	-5,925%
Profit Margin	-225.77%	-242.08%	-7,144.44%	-624.67%	-814.49%	-5,600%
Free Cash Flow Margin	-169.12%	-239.36%	-5,877.77%	-551.94%	-740.57%	-5,087.5%
EBITDA	-589	-571	-593	-462	-571	--
EBITDA Margin	-166.85%	-258.37%	-6,588.88%	-600%	-827.53%	--
D&A For EBITDA	5	6	6	6	5	--
EBIT	-594	-577	-599	-468	-576	-474
EBIT Margin	-168.27%	-261.08%	-6,655.55%	-607.79%	-834.78%	-5,925%
Effective Tax Rate	-0.12%	-0.18%	--	--	--	--

BridgeBio Pharma Inc (BBIO) Price

BBIO Stock Price Chart

BBIO Income

Follow-Up Questions